Connect your AI

Veracyte VCYT Change in Other Assets

Change in Other Assets at other companies

Guardant HealthGH

$7.24M+136%

Natera, Inc.NTRA

$17.06M+82.4%

Labcorp HoldingsLH

-$4M+91.1%

DanaherDHR

$40M+25.0%

Adaptive BiotechnologiesADPT

$824K+269%

IQVIAIQV

-$54.5M-3,014%

Other financials

Income statement

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

Market cap$4.29B+10.7%

Profitability

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Veracyte's change in other assets?: Veracyte (VCYT) reported change in other assets of $132K in Q1 2026.
How has Veracyte's change in other assets changed year-over-year?: Veracyte's change in other assets increased by 208.2% year-over-year, from -$122K to $132K.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.